SCHEMBL4163471

SCHEMBL4163471

[O]CCCNc1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
MAPT P10636 5/20 0.47
ALDH1A1 P00352 4/20 0.47
HTT P42858 4/20 0.47
LMNA P02545 3/20 0.47
EPHX1 P07099 3/20 0.44
RAB9A P51151 2/20 0.44
ICMT O60725 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.43
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDR P35968 1/20 0.42
EGFR P00533 1/20 0.41
MAOB P27338 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4159702 0.89 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL11115361 0.88 MAPT (0.54) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL11527837 0.84 MAPT (0.56) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL11114661 0.83 MAPT (0.65) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL4770833 0.83 EGFR (0.51) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL11113758 0.83 ALDH1A1 (0.48) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL4822806 0.81 CAMK2D (0.48) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL2920696 0.81 EPHX1 (0.59) KMT2AMAPTALDH1A1EPHX1EGFR
SCHEMBL11115302 0.81 MAPT (0.52) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL11111478 0.81 KDR (0.58) MEN1KMT2AMAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088438-A1 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS LABORATORIOS SALVAT, S.A. (ES) 2009-04-02 US disclosed
US-7423172-B2 Tyrosine derivatives as PPAR-γ-modulators LABORATORIOS SALVAT, S.A. (ES) 2008-09-09 US disclosed
US-20070276043-A1 Tyrosine Derivatives As Ppar-Gamma-Modulators LABORATORIES SALVAT, S.A. (ES) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088438-A1 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS PPARG, PPARD, TYRO3 MEN1 4879/4885KMT2A 2852/4885MAPT 2739/4885
US-20070276043-A1 Tyrosine Derivatives As Ppar-Gamma-Modulators PPARG, PPARD, PPARA MEN1 4879/4885KMT2A 2792/4885MAPT 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.